Royal Bank of Canada
ERAS icon

Royal Bank of Canada’s Erasca ERAS Stock Holding History

Royal Bank of Canada’s Portfolio ERAS Stock Details ERAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4K Sell
239
-4,767
-95% -$56.3K ﹤0.01% 6483
2025
Q4 		$18K Sell
5,006
-663,750
-99% -$1.87M ﹤0.01% 6104
2025
Q3 		$1.46M Buy
668,756
+63,366
+10% +$101K ﹤0.01% 3665
2025
Q2 		$769K Buy
605,390
+593,591
+5,031% +$795K ﹤0.01% 4128
2025
Q1 		$16K Sell
11,799
-11,353
-49% -$19.5K ﹤0.01% 5990
2024
Q4 		$58K Buy
23,152
+4,465
+24% +$12.2K ﹤0.01% 5611
2024
Q3 		$51K Sell
18,687
-190,925
-91% -$538K ﹤0.01% 5688
2024
Q2 		$495K Buy
209,612
+207,718
+10,967% +$448K ﹤0.01% 4024
2024
Q1 		$4K Sell
1,894
-23,423
-93% -$46.8K ﹤0.01% 6493
2023
Q4 		$54K Buy
25,317
+11,768
+87% +$24.8K ﹤0.01% 5946
2023
Q3 		$27K Buy
13,549
+5,131
+61% +$13.1K ﹤0.01% 6077
2023
Q2 		$23K Buy
8,418
+4,374
+108% +$12.5K ﹤0.01% 6138
2023
Q1 		$12K Sell
4,044
-3,305
-45% -$12K ﹤0.01% 6230
2022
Q4 		$32K Buy
7,349
+6,557
+828% +$44.5K ﹤0.01% 6105
2022
Q3 		$6K Buy
792
+426
+116% +$3.43K ﹤0.01% 6656
2022
Q2 		$2K Sell
366
-32,076
-99% -$210K ﹤0.01% 6941
2022
Q1 		$279K Buy
32,442
+28,137
+654% +$326K ﹤0.01% 4783
2021
Q4 		$67K Buy
4,305
+1,987
+86% +$34K ﹤0.01% 6201
2021
Q3 		$49K Buy
+2,318
New +$47.8K ﹤0.01% 6173

Other funds holding ERAS

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

Royal Bank of Canada's ERAS Position: Q1 2026 in Review

Royal Bank of Canada reduced its Erasca (ERAS) stake by 95% in Q1 2026, selling an estimated $56.3K and leaving 239 shares worth $4K. The position accounts for ﹤0.01% of the portfolio, ranked #6483.

Royal Bank of Canada first reported a position in ERAS in Q3 2021 and has held it in 19 quarters since. The position peaked at $1.46M in Q3 2025. 225 funds tracked by Wall St. Rank hold ERAS as of Q1 2026.

  • Royal Bank of Canada held 239 shares of Erasca worth $4K as of Q1 2026.
  • Royal Bank of Canada sold 4,767 Erasca shares in Q1 2026, an estimated $56.3K.
  • Erasca made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #6483 holding.
  • Royal Bank of Canada first reported a position in Erasca in Q3 2021 and has held it in 19 quarters since.
  • Royal Bank of Canada's Erasca position peaked at $1.46M in Q3 2025.
  • 225 funds tracked by Wall St. Rank held Erasca as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.